Positive allosteric modulation of metabotropic glutamate receptor 5 down-regulates fibrinogen-activated microglia

Thomas M Piers1, Simon J Heales, Jennifer M Pocock

  • 1Cell Signalling Laboratory, Department of Neuroinflammation, Institute of Neurology, University College London, London WC1N 1PJ, UK.

Neuroscience Letters
|October 22, 2011
PubMed

Insights

Metabotropic glutamate receptor 5 (mGluR5) activation protects neurons from fibrinogen-induced neurotoxicity. Targeting microglial mGluR5 offers a potential strategy against neuroinflammation triggered by blood-borne proteins in neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Neuroimmunology
  • Neuropharmacology

Background:

  • Microglial activation and blood-brain barrier (BBB) dysfunction are implicated in neurodegenerative disorders.
  • Blood-borne proteins, such as fibrinogen (FG), can infiltrate the CNS and activate microglia, leading to a neurotoxic phenotype.

Purpose of the Study:

  • To investigate the role of metabotropic glutamate receptor 5 (mGluR5) and mGluR2 in modulating fibrinogen-induced neurotoxicity and microglial activation.
  • To explore the potential of targeting mGluR5 for neuroprotection against blood protein-triggered neuroinflammation.

Main Methods:

  • Utilized neuronal cultures to assess FG-mediated neurotoxicity and ERK1/2 phosphorylation.
  • Examined the effects of direct mGluR5 and mGluR2 activation on FG-mediated microglial activation.

Main Results:

  • FG-induced neurotoxicity and ERK1/2 phosphorylation in neurons were significantly reduced by mGluR5 activation, but not mGluR2.
  • FG-mediated microglial activation was down-regulated by direct mGluR5 activation on microglia, but not mGluR2.

Conclusions:

  • Activation of microglial mGluR5 can protect neurons from the detrimental effects of blood-borne proteins like fibrinogen.
  • Targeting microglial mGluR5 presents a promising therapeutic avenue for mitigating innate inflammatory responses in neurodegenerative conditions.